Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
以色列公司公佈2023年創紀錄的收入，希望將大麻業務轉移到 “第三方”
Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN) announced on Thursday its financial results for the fourth quarter and full-year period ending December 31, 2023.
Evogene Ltd.（納斯達克股票代碼：EVGN）（TASE：EVGN）週四公佈了截至2023年12月31日的第四季度和全年業績。
In the fourth quarter revenues amounted to $578 000, down 12% year-over-year. However, the Rehovot, Israel-based cannabis company reported $5.6 million in revenue for 2023, representing a year-over-year increase of 237% from $1.7 million in 2022.
第四季度收入爲57.8萬美元，同比下降12％。但是，這家總部位於以色列雷霍沃特的大麻公司報告稱，2023年的收入爲560萬美元，較2022年的170萬美元同比增長237％。
"The Evogene Group has experienced a transformative year with industry perception of our technology and products translating into growing collaborations with world-leading companies," Ofer Haviv, Evogene's president and CEO, said in a press release.
Evogene總裁兼首席執行官奧弗·哈維夫在一份新聞稿中說：“Evogene集團經歷了變革性的一年，業界對我們的技術和產品的看法轉化爲與世界領先公司的合作不斷髮展。”
Haviv praised the company's "collaboration momentum" referring to...
Haviv稱讚了該...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。